Article thumbnail

Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]

By Christine L Roberts, Jonathan M Morris, Kristen R Rickard, Warwick B Giles, Judy M Simpson, George Kotsiou and Jennifer R Bowen
Topics: Study Protocol
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3061957
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A: Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev
  2. (1992). A: The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labor. Arch Gynecol Obstet
  3. (1989). Association of Chlamydia trachomatis and Mycoplasma hominis with intrauterine growth retardation and preterm delivery. The John Hopkins Study of Cervicitis and Adverse Pregnancy Outcome.
  4. (2003). CAC: Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect
  5. (2002). Choriodecidual infection and preterm birth. Nutr Rev
  6. (1995). CJ: A prospective study of the microbiological environment of the genitourinary tract in Hong Kong Chinese women during pregnancy.
  7. (2004). Control of communicable diseases manual: an official report of the American Public Health Association.
  8. (2007). Czeizel AE: Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol
  9. (2008). Epidemiology and causes of preterm birth. Lancet
  10. (1998). Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy.
  11. (2004). GL: Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev
  12. (2009). Health issues of the late preterm infant. Pediatr Clin North Am
  13. (2006). Interconceptional antibiotics to prevent spontaneous preterm birth: a randomized clinical trial.
  14. (2000). Interventions for treating genital chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev
  15. (2002). Interventions for treating trichomoniasis in pregnancy. Cochrane Database Syst Rev
  16. (2008). LW: An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet
  17. (1992). Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis
  18. (1995). Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation.
  19. (2004). Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ
  20. (2008). secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet
  21. (2011). Statistics Unit: Australia’s Mothers and Babies Reports [http://www.preru.unsw.edu.au/PRERUWeb.nsf/page/Perinatal+Statistics], (accessed
  22. (2005). The economic consequences of preterm birth during the first 10 years of life. BJOG
  23. (2000). The impact of regular vaginal pH screening on the diagnosis of bacterial vaginosis in pregnancy. J Fam Pract
  24. (1992). The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin Med
  25. (2000). Vaginal candidosis: epidemiological and etiological factors.
  26. (2007). Vulvovaginal candidosis. Lancet
  27. (2000). WW: Intrauterine infection and preterm delivery.